Thymalin [Peptide]

Description

Thymalin Peptide

The product is only intended for laboratory research use and not for human consumption. 

Available quantities:

• 5 mg
• 20 mg
• 50 mg

Product Information 

Product Name	Thymalin [Peptide]
Peptide purity (HPLC)	98-99%
Molecular Formula	C33H54N12O15
Molecular Weight	858.864 g/mol
CAS	63958-90-7
Source	Synthetic
Form	Powder
Shelf Life	Up to 2 years in powder form under recommended conditions

Molecular Sequence of Thymalin Peptide 

H–Glu–Trp–Gly–NH₂

• H– indicates the free amine group at the N-terminus.

• –NH₂ indicates C-terminal amidation, which increases peptide stability and resistance to enzymatic breakdown.

Handling and Storage of Thymalin Peptide 

The peptide compound should be stored in a cool and dry place to maximize its stability. For Thymalin lyophilized peptides, it is recommended to store them in the refrigerator between 2°C and 8°C (36°F–46°F) in an airtight container. 

Lab user exposure: 

• Avoid prolonged or repeated exposure.
• Avoid inhalation.
• Avoid contact with eyes or skin.
• The product is non-hazardous for lab-to-lab or air transportation.
• Handle inside standard laboratory containment.
• Use gloves, a lab coat, and protective eyewear.

Redissolving:

• Can be reconstituted in sterile distilled water or suitable buffer solutions.
• A small amount of DMSO or 0.1% TFA may be used to test or improve solubility.
• Mix gently, avoid high-temperature heating. 

Choice of container and precautions:

• Low-binding sterile polypropylene to prevent absorption
• Borosilicate glass vials to prevent absorption in the glass walls
• Avoid polystyrene
• Avoid lab plastic containers 

Overview of the Thymalin Peptide 

Thymalin is a peptide complex derived from the extract of the thymus gland. It contains short peptides (2-8 amino acids) that may be studied in experimental models for potential to regulate gene expression and the immune system. 

In preclinical studies, Thymalin is being researched for its potential to influence immune and cytokines related pathways in laboratory models. 

Working Mechanism of Thymalin Peptide

• Preclinical studies suggest that Thymalin contains short peptides EW, KE, and EDP that intercellular nuclei bind to specific DNA sequences. Upon binding to a DNA sequence, it has potential to remodel certain gene expressions in experimental models.
• Some laboratory studies indicate that the compound may be studied for its potential to stem cells related pathways , which often declines with age or illness in laboratory research models.  
• Research studies suggest that Thymalin may influence apoptosis related pathways in certain immune cells in experimental models.

Besides potential working mechanisms, the peptide also has some laboratory observations.

• Mood fluctuations in experimental models 
• Nausea under laboratory settings 
• Headache in lab models

TFA Salt Form 

Thymalin is provided in its TFA salt form. Residual trifluoroacetate content is typically up to 10% w/w. It depends on the final formulation and lyophilization conditions. The exact TFA content can be confirmed by batch-specific COA.

Disclaimer

Thymalin peptide is intended exclusively for laboratory research purposes. RCDbio products are not intended to diagnose, treat, cure, or prevent any disease. The Food and Drug Administration has not evaluated the statements on our website. By purchasing, you agree to our Terms and Conditions.